(Total Views: 1022)
Posted On: 12/08/2022 2:43:45 PM
Post# of 153994
Just listened to the CC for the third time. Amazing how much I missed when it was broadcast yesterday.
So, we have a trial for NASH that the lead investigator indicates leronlimab has demonstrated measurable improvement on liver function and,
We have a veteran physician with 38 years of experience telling us that no other treatment out there is as effective and safe for the treatment of various cancers with leronlimab and,
We have a veteran investigator reporting that he has seen evidence of a cure for HIV, (NIH funded trial) and an effective treatment for NASH/HIV and wants additional trials and,
The company stock can be purchased for 32 cents a share.
Amazing!
So, we have a trial for NASH that the lead investigator indicates leronlimab has demonstrated measurable improvement on liver function and,
We have a veteran physician with 38 years of experience telling us that no other treatment out there is as effective and safe for the treatment of various cancers with leronlimab and,
We have a veteran investigator reporting that he has seen evidence of a cure for HIV, (NIH funded trial) and an effective treatment for NASH/HIV and wants additional trials and,
The company stock can be purchased for 32 cents a share.
Amazing!
(19)
(0)
